Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Entasis Announces Positive Topline Results from Phase 2 Trial of ETX2514SUL

americanpharmaceuticalreviewAugust 15, 2018

Tag: Entasis , ETX2514SUL

PharmaSources Customer Service